Tessera Defense and Homeland Security Inc.

Item 5.07. Submission of Matters to a Vote of Security Holders. BiomX Inc. (the “Company”) held a Special Meeting of Stockholders (the “Special Meeting”) on August 25, 2026 in a virtual meeting format. As of August 10, 2026, the record date for the Special Meeting, there were 26,559,607 shares of the Company’s common stock, par value $0.0001 per share, outstanding and entitled to vote. A total of 9,813,430 shares were represented in person (virtually) or by proxy at the Special Meeting, representing approximately 36.9% of the shares entitled to vote and constituting a quorum. The vote results detailed below represent the final results as certified by the Inspector of Elections. The number of votes cast for or against, as well as the number of abstentions and broker non-votes as to each proposal, are set forth below. Proposal 1: Approval of the Issuance Proposal. The Company’s stockholders approved, for purposes of Sections 712 and 713 of the NYSE American Company Guide, the issuance of shares of the Company’s common stock, and securities convertible into or exercisable for common stock, to Mandragola Ltd. in connection with the Company’s acquisition of controlling equity interests in Dr. Frucht Systems Ltd., including shares issued or issuable in connection with the Line of Credit and, at the Company’s election, in satisfaction of the Revenue Bonus. The voting results were as follows: For Against Abstain Broker Non-Votes ───────────────────────────────────────────────────────────── 9,313,228 429,645 70,557 0 Proposal 2: Approval of the Reverse Split Proposal. The Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect one or more reverse stock splits of the issued and outstanding common stock at an aggregate ratio of not less than 1-for-5 and not more than 1-for-20, with the exact ratio and timing to be determined by the Board of Directors in its discretion at any time prior to the first anniversary of the Special Meeting, and providing that, if any reverse stock split is implemented, the number of authorized shares of common stock will be reduced from 750,000,000 to 150,000,000. The voting results were as follows: For Against Abstain Broker Non-Votes ───────────────────────────────────────────────────────────── 9,293,937 453,526 65,967 0 Proposal 3: Ratification of the Appointment of the Independent Registered Public Accounting Firm. The Company’s stockholders ratified the appointment of Barzily & Co. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The voting results were as follows: For Against Abstain Broker Non-Votes ───────────────────────────────────────────────────────────── 9,575,900 176,487 61,043 0 Proposal 4: Adjournment Proposal. The Company’s stockholders approved the proposal to adjourn the Special Meeting, if necessary or appropriate, to solicit additional proxies if there were insufficient votes at the time of the Special Meeting to approve one or more of the foregoing proposals. The voting results were as follows: For Against Abstain Broker Non-Votes ───────────────────────────────────────────────────────────── 9,529,079 237,990 46,361 0 Because Proposals 1, 2 and 3 received sufficient votes for approval, no adjournment of the Special Meeting was necessary.